Drug intelligence / Profile preview

nicotine + bupropion + varenicline

Development stage
Preclinical
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Transdermal, Sublingual, Intranasal, Inhalation
01

Overview

A combination therapy approach for smoking cessation that utilizes three different FDA-approved smoking cessation medications: nicotine replacement therapy, bupropion sustained-release (SR), and varenicline. Each medication works through different mechanisms to help reduce nicotine cravings and withdrawal symptoms. Varenicline acts as a partial agonist at α4β2 neuronal nicotinic acetylcholine receptors, bupropion works through noradrenergic and dopaminergic systems, and nicotine replacement therapy provides controlled doses of nicotine to reduce withdrawal symptoms.

02

Targets

CHRNA7 (α7 nicotinic receptor)α4β2 nAChR (Nicotinic acetylcholine receptor alpha4 beta2 subtype)α3β4 nAChR (α3β4 nicotinic receptor)DAT (Sodium-dependent dopamine transporter)NET (Sodium-dependent noradrenaline transporter)

Beyond the preview

Go deeper on nicotine + bupropion + varenicline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotine + bupropion + varenicline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call